本港近日疫情缓和 莎莎(00178.HK)必瘦站(01830.HK)续涨12%及11%破顶
本港近日疫情缓和,港府有意於春节过後放宽限制措施。必瘦站(01830.HK)及莎莎(00178.HK)四连涨,尤其是前者股价屡创纪录高,最高见4.75元,现造4.64元,续升11%,成交已达525万股;後者最高见1.71元,创逾一年高,现造1.67元,续升12%,成交增至4,370万股。
卓悦(00653.HK)续升9.9%报0.156元,股价重越百天线(0.148元),成交增至1,938万股。停牌近一年的自然美(00157.HK)达成所有复牌条件後,今早复市曾飙升1.3倍至1.52元纪录高,其後升幅收窄至29%报0.84元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.